Literature DB >> 16794423

Premature ovarian failure.

Apollo Meskhi1, Mourad W Seif.   

Abstract

PURPOSE OF REVIEW: To summarize current knowledge about premature ovarian failure (POF) with an emphasis on recent developments regarding its management. RECENT
FINDINGS: The incidence of POF is increasing largely due to improved survival rates of cancer patients treated with radiation and chemotherapy. Delayed diagnosis and management of POF leads to suboptimal outcomes. Anticipation and early detection of this condition in high-risk women by means of ovarian function testing, followed by early institution of appropriate management could improve outcomes. Choice of strategies should vary depending on the age of onset, associated symptoms and fertility aspirations of the individual, and should change with the patient's advancing age.
SUMMARY: Early assessment of the individual's risk of developing POF, development of a strategic management plan, and timely commencement of infertility and hormone deficiency treatment, together with counselling in an integrated management plan should improve both the short and long-term health of those with POF.

Entities:  

Mesh:

Year:  2006        PMID: 16794423     DOI: 10.1097/01.gco.0000233937.36554.d3

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  17 in total

Review 1.  Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause.

Authors:  Emanuele Pelosi; Eleanor Simonsick; Antonino Forabosco; Jose Elias Garcia-Ortiz; David Schlessinger
Journal:  Biol Reprod       Date:  2015-04-22       Impact factor: 4.285

2.  Mapping of an origin of DNA replication in the promoter of fragile X gene FMR1.

Authors:  Bruna P Brylawski; Paul D Chastain; Stephanie M Cohen; Marila Cordeiro-Stone; David G Kaufman
Journal:  Exp Mol Pathol       Date:  2006-12-28       Impact factor: 3.362

3.  The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.

Authors:  Queenie Ho Yan Wong; Tracy Wing Yee Yeung; Sofie Shuk Fei Yung; Jennifer Ka Yee Ko; Hang Wun Raymond Li; Ernest Hung Yu Ng
Journal:  J Assist Reprod Genet       Date:  2018-03-09       Impact factor: 3.412

4.  Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.

Authors:  C L Shapiro; S Halabi; V Hars; L Archer; D Weckstein; J Kirshner; W Sikov; E Winer; H J Burstein; C Hudis; C Isaacs; R Schilsky; E Paskett
Journal:  Eur J Cancer       Date:  2011-02-14       Impact factor: 9.162

5.  Screening of follicle-stimulating hormone receptor gene in women with premature ovarian failure in southern Brazil and associations with phenotype.

Authors:  L C Vilodre; M B F Kohek; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

6.  Cardiovascular autonomic dysfunction in primary ovarian insufficiency: clinical and experimental evidence.

Authors:  Silvia Goldmeier; Kátia De Angelis; Karina Rabello Casali; César Vilodre; Fernanda Consolim-Colombo; Adriane Belló Klein; Rodrigo Plentz; Polimara Spritzer; Maria-Cláudia Irigoyen
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

7.  Utility of complete blood count parameters to detect premature ovarian insufficiency in cases with oligomenorrhea/amenorrhea.

Authors:  Ilhan Sanverdi; Cetin Kilicci; Ebru Cogendez; Cigdem Abide Yayla; Enis Ozkaya
Journal:  J Clin Lab Anal       Date:  2017-12-15       Impact factor: 2.352

8.  Premature ovarian failure in mice with oocytes lacking core 1-derived O-glycans and complex N-glycans.

Authors:  Suzannah A Williams; Pamela Stanley
Journal:  Endocrinology       Date:  2011-01-14       Impact factor: 4.736

Review 9.  A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency.

Authors:  A Falorni; V Minarelli; C M Eads; C M Joachim; L Persani; R Rossetti; P Yurttas Beim; V A Pellegrini; P F Schnatz; S Rafique; K Kissell; K A Calis; V Popat; L M Nelson
Journal:  Panminerva Med       Date:  2014-10-07       Impact factor: 5.197

10.  Analysis of in vitro follicle development during the onset of premature ovarian insufficiency in a mouse model.

Authors:  Heidy Kaune; Sairah Sheikh; Suzannah A Williams
Journal:  Reprod Fertil Dev       Date:  2017-08       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.